California embryonic stem cell dollars: beyond the embryonic phase

According to the newest Request For Applications (RFA) of the California Institute for Regenerative Medicine (CIRM), the New Cell Line Awards will support two categories of research: Category 1: Derivation of new hESC lines using excess or rejected early stage human embryos generated by in vitro fertilization. Category 2: Derivation of pluripotent human stem cell… Continue reading California embryonic stem cell dollars: beyond the embryonic phase